Involvement of δ1 and δ2 opioid receptor subtypes in the development of physical dependence on morphine in mice

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 1-2, 1997, Pages 293-299

  Suzuki, Tsutomu ^a   Tsuji, Minoru ^a   Mori, Tomohisa ^a   Misawa, Miwa ^a   Nagase, Hiroshi ^b  

^a HOSHI UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

Opioid receptors; BNTX; Morphine; NTB; NTI; Physical dependence

Indexed keywords

7 BENZYLIDENENALTREXONE; DELTA OPIATE RECEPTOR; MORPHINE; NALOXONE; NALTRIBEN; NALTRINDOLE; NALTRINDOLE 5' ISOTHIOCYANATE; OPIATE ANTAGONIST; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; BENZYLIDENE COMPOUNDS; MALE; MICE; MICE, INBRED STRAINS; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, DELTA; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0030946470     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00319-X     Document Type: Article

References (50)

1. Abdelhamide, E. E.; Sultana, M.; Portoghese, P. S.; Takemori, A. E. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258:299-303; 1991a.
2. Abdehamide, E. E.; Takemori, A. E. Characteristics of μ and δ opioid binding sites in striatal slices of morphine-tolerant and -dependent mice. Eur. J. Pharmacol. 198:157-163; 1991b.
3. Aceto, M. D.; Dewey, W. L.; Chang, J.-K.; Lee, N. M. Dynorphin-(1-13): Effect in nontolerant and morphine-dependent rhesus monkeys. Eur. J. Pharmacol. 83:139-142; 1982.
4. Aceto, M. D.; Dewey, W. L.; Portoghese, P. S.; Takemori, A. E. Effect of β-funaltrexamine (β-FNA) on morphine dependence in rats and monkeys. Eur. J. Pharmacol. 123:387-393; 1986.
5. Cowan, A.; Zhu, X. Z.; Mosberg, H. I.; Omnaas, R. J.; Porreca, F. Direct dependence studies in rats with agents selective for different types of opioid receptor. J. Pharmacol. Exp. Ther. 246: 950-955; 1988.
6. Delander, G. E.; Portoghese, P. S.; Takemori, A. E. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence. J. Pharmacol. Exp. Ther. 231:91-96; 1984.
7. Gmerek, D.; Woods, J. H. Effect of β-funaltrexamine in normal and morphine dependent rhesus monkeys: Observation studies. J. Pharmacol. Exp. Ther. 235:296-301; 1985.
8. Green, P. G.; Lee, N. M. Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration. Eur. J. Pharmacol. 145:267-272; 1988.
9. 5]enkephalin. Eur. J. Pharmacol. 165: 1-10; 1989.
10. Horan, P.; Tallarida, R. J.; Haaseth, R. C.; Matsunaga, T. O.; Hruby, V. J.; Porreca, F. Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: Supra- and subadditivity. Life Sic. 50:1535-1541; 1992.
11. Jiang, Q. I.; Mosberg, H. I.; Porreca, F. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J. Pharmacol. Exp. Ther. 254:683-689; 1990.
12. 6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257:1069-1075; 1991.
13. Lee, N. M.; Leybin, L.; Chang, J. K.; Loh, H. H. Opiate and peptide interaction: Effect of enkephalin on morphine analgesia. Eur. J. Pharmacol. 68:181-185; 1980.
14. Liu-Chen, L-Y.; Li, S.; Wheeler-Aceto, H.; Cowan, A. (1991) Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociception. Eur. J. Pharmacol. 203:195-202; 1991.
15. Maldonado, R.; Dauge, V.; Callebert, J.; Villette, J. M.; Fourine-Zaluski, M.-C.; Feger, J.; Roques, B. P. Comparison of selective and complete inhibitors of enkephalin-degrading enzymes on morphine withdrawal syndrome. Eur. J. Pharmacol. 165:199-207; 1989.
16. 2]deltorphine II in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258:583-587; 1991.
17. 2 opioid receptors in the development of morphine dependence in mice. J. Pharmacol. Exp. Ther. 264:1141-1145; 1993a.
18. 2 opioid receptors in acute dependence on morphine in mice. J. Pharmacol. Exp. Ther. 265:1325-1327; 1993b.
19. Miyamoto, Y.; Bowen, W. D.; Portoghese, P. S.; Takemori, A. E. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice. J. Pharmacol. Exp. Ther. 270:37-39; 1994.
20. Narita, M.; Suzuki, T.; Misawa, M.; Nagase, H. Effects of kappa opioids on the morphine-induced pharmacological actions. Eur. J. Pharmacol. 183:2328; 1990.
21. Narita, M.; Suzuki, T.; Funada, M.; Misawa, M.; Nagase, H. Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by κ-opioid receptor activation in mice. Life Sic. 52:397-404; 1993a.
22. Narita, M.; Suzuki, T.; Funada, M.; Misawa, M.; Nagase, H. Involvement of δ-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice. Psychopharmacology 111:423-426; 1993b.
23. Nylander, I.; Vlaskovska, M.; Terenius, L. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats. Psychopharmacology 118:391-400; 1995.
24. Portoghese, P. S.; Larson, D. L.; Sayre, L. E.; Fries, D. S.; Takemori, A. E. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activity. J. Med. Chem. 23:233-234; 1980.
25. Portoghese, P. S.; Sultana, M.; Takemori, A. E. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur. J. Pharmacol. 146:185-186; 1988.
26. Portoghese, P. S.; Sultana, M.; Takemori, A E. Naltrindole 5′-isothiocyanate: A nonequilibrium, highly selective δ opioid receptor antagonist. J. Med. Chem. 33:1547-1548; 1990a.
27. Portoghese, P. S.; Sultana, M.; Takemori, A. E. Design of peptidomimetic δ opioid antagonists using the message-address concept. J. Med. Chem. 33:1714-1720; 1990b.
28. Portoghese, P. S.; Nagase H.; Maloney-Huss, K. E.; Lin, C. E.; Takemori, A. E. Role of spacer and address components in peptidomimetic δ opioid receptor antagonists related to naltrindole. J. Med. Chem. 34:1715-1720; 1991.
29. 1-opioid receptor antagonist: 7-benzylidenenaltrexone. Eur. J. Pharmacol. 218:195-196; 1992.
30. 3H]-leucine enkephalin to a particulate fraction of rat brain. Mol. Pharmacol. 21:538-547; 1982a.
31. Rothman, R. B.; Westfall, T. C. Allosteric coupling between morphine and enkephalin receptors in vivo. Mol. Pharmacol. 21:548-557; 1982b.
32. Rothman, R. B.; Long, J. B.; Bykov, V.; Jacobson, A. E.; Rice, K. C.; Holaday, J. W. β-FNA binds irreversibly to opiate receptor complex: in vivo and vitro evidence. J. Pharmacol. Exp. Ther. 247:405-416; 1988.
33. Sanchez-Blazquez, P.; Garzon, J. Evaluation of δ receptor mediation of supraspinal opioid analgesia by in vivo protection against the β-funaltrexamine antagonist effect. Eur. J. Pharmacol. 159: 9-23; 1989.
34. Sofuoglu, M.; Portoghese, P. S.; Takemori, A. E. Differential antagonism of delta opioid agonists bynaltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257:676-680; 1991.
35. 2 opioid receptor subtypes. Life Sci. 55:PL79-84; 1994.
36. Suzuki, T.; Yoshii, T.; Yanaura, S. Induction of physical dependence on morphine in mice by the drug-admixed food method. Jpn. J. Pharmacol. 34:319-325; 1984.
37. 1 receptor in physical dependence on morphine using the mu receptor deficient CXBK mouse. Life Sci. 50:849-856; 1992a.
38. Suzuki, T.; Narita, M.; Takahashi, Y.; Misawa, M.; Nagase, H. Effects of norbinaltrophimine on the development of analgesic tolerance to and physical dependence on morphine. Eur. J. Pharmacol. 213:91-97; 1992b.
39. Suzuki, T.; Yoshiike, M.; Mizoguchi, H.; Kamei, J.; Misawa, M.; Nagase, H. Blockade of δ-opioid receptors prevents morphine-induced place preference in mice. Jpn. J. Pharmacol. 66:131-137; 1994.
40. Suzuki, T.; Mori, T.; Tsuji, M.; Misawa, M.; Nagase, H. The role of δ-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences. Life Sci. 55:PL339-344; 1994.
41. Suzuki, T.; Tsuji, M.; Mori, T.; Misawa, M.; Endoh, T.; Nagase, H. Effects of a highly selective nonpeptide δ opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice. Life Sci. 57:155-168; 1995.
42. Suzuki, T.; Tsuji, M.; Mori, T.; Misawa, M.; Endoh, T.; Nagase, H. Effect of the highly selective and nonpeptide δ opioid receptor agonist TAN-67 on the morphine-induced place preference in mice. J. Pharmacol. Exp. Ther. 279:177-185; 1996.
43. Takemori, A. E.; Larson, D. L.; Portoghese, P. S. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur. J. Pharmacol. 70:445-451; 1981.
44. Takemori, A. E.; Portoghese, P. S. Evidence for the interaction of morphine with kappa and delta opioid receptors to induced analgesia in β-funaltrexamine-treated mice. J. Pharmacol. Exp. Ther. 243:91-94; 1987.
45. Takemori, A. E.; Sultana, M.; Nagase, H.; Portoghese, P. S. Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone. Life Sci. 50:1491-1495; 1992.
46. 5]enkephalin on rat brain opioid receptors. Eur. J. Pharmacol. 201:209-214; 1991.
47. Uhl, G. R.; Ryan, J. P.; Schwartz, J. P. Morphine alters preproenkephalin gene expression. Brain Res. 459:391-397; 1988.
48. Vaught, J. L.; Takemori, A. E. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance, and dependence. J. Pharmacol. Exp. Ther. 208: 86-90; 1979.
49. Ward, S. J.; Portoghese, P. S.; Takemori, A. E. Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine. J. Pharmacol. Exp. Ther. 220:494-498; 1982.
50. Yamamoto, T.; Ohno, M.; Ueki, S. A selective κ-opioid agonist, U-50, 588H, blocks the development of tolerance to morphine analgasis in rats. Eur. J. Pharmacol. 156:173-176; 1988.